1 unknown, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
Follow Antiviral Agents: new trials by email Literature Review of Antiviral Agents trials Research Report on Antiviral Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Women in Dual With Dolutegravir Antiviral Agents - HIV Infections | Phase 3 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 290 | 2023-10-01 | 2023-09-13 |
| Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection alpha1-proteinase inhibitor, Antiviral Agents - Covid19, Pneumonia, Viral | Phase 3 | Withdrawn | Blessing Corporate Services, Inc | 2021-01-01 | 2020-12-21 |
COVID-19 (1) · HIV Infections (1) · Pneumonia, Viral (1)
Blessing Corporate Services, Inc (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)
Italy (1) · United States (1)
Humam Farah, MD (1)